Topifort-NX Topical Suspension
By Topifort-NX
15ml Solution in a Bottle

Composition
Clotrimazole(2% w/v) + Clobetasol(0.05% w/v) + Neomycin(3500u/ml)

Manufacturer - Franco-Indian Pharmaceuticals Pvt Ltd
20, Dr. E. Moses Road, Mahalaxmi, Mumbai - 400 011

Expires on or after
November, 2025

liver
When using Topifort-NX Topical Suspension, it is important to consider the caution related to the liver. Based on the available data, no interactions have been found or established in relation to the liver. This means that there are no specific safety concerns or advice regarding the use of Topifort-NX Topical Suspension and its impact on the liver. However, it is always recommended to consult with your doctor for proper guidance before using any medication, including this topical suspension. Your healthcare provider can offer personalized advice based on your individual health status and any potential risks or considerations that may apply to you.

kidney
No interaction with kidneys found for Topifort-NX Topical Suspension.

alcohol
No interaction has been found between alcohol and Topifort-NX Topical Suspension. It is important to be cautious during pregnancy when using this medication.

driving
When using Topifort-NX Topical Suspension, it is safe to drive as no interactions or cautions related to driving have been identified.

pregnancy
Topifort-NX Topical Suspension may not be safe during pregnancy. Animal studies show potential harm to the developing baby. Consult your doctor for a careful evaluation of benefits versus risks.

breastfeeding
Topifort-NX Topical Suspension may be safely used during breastfeeding. Limited human data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | DERMA |
Action Class | - |
₹47
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024